Articles related to PRACTICE MANAGEMENT

The first biologic was approved in 1982, and since then, have become one of the fastest-growing segments of the US pharmaceutical market. Biologics are complex therapies used to treat a wide variety of conditions – conditions that are often untreatable by any other drug – and physicians should be up to speed on these four classes of biologic agents, which are used to treat cancer or inflammatory disease.

In this Special Report, the American Society of Clinical Oncology (ASCO) publishes guidance for oncology practices on how to safely restore patient access to diagnostics, treatments, and other critical cancer care services.

This JAMA “Viewpoint” outlines the frameworks that should be used to inform decisions about how to modify cancer treatment based on patient and cancer-specific factors during these unprecedented COVID-19 times.